Biomet, a device company focused on the manufacturing of orthopedic products, has received FDA clearance for its Active Articulation E1 Dual Mobility Hip System, according to a company news release.
The Active Articulation Hip System merges the concept of dual mobility with Biomet's exclusive E1 Antioxidant Infused technology and a proven cup design. The dual mobility hip concept utilizes a small femoral head that articulates within polyethylene. The large polyethylene bearing, when triggered, acts as a large head bearing that articulates within a metal cup.
Read the company news release about FDA approval of Biomet's Active Articulation Hip System (pdf).
Related Articles on Biomet:
Biomet Co-Founder Recognized as Entrepreneurial Leader
Biomet Acquires Massachusetts' Cytosol Laboratories
Biomet Increases Net Sales by 2% During 1Q FY 2011, Less Than Expected
The Active Articulation Hip System merges the concept of dual mobility with Biomet's exclusive E1 Antioxidant Infused technology and a proven cup design. The dual mobility hip concept utilizes a small femoral head that articulates within polyethylene. The large polyethylene bearing, when triggered, acts as a large head bearing that articulates within a metal cup.
Read the company news release about FDA approval of Biomet's Active Articulation Hip System (pdf).
Related Articles on Biomet:
Biomet Co-Founder Recognized as Entrepreneurial Leader
Biomet Acquires Massachusetts' Cytosol Laboratories
Biomet Increases Net Sales by 2% During 1Q FY 2011, Less Than Expected